RESPIRATORY MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2023-12-06 ms9000001233094927 来自浙江省

11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2023-11-07 嘻嘻号来自江苏省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：未送审临床预测模型有外部验证，投稿7天后被拒

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2021-04-21 想不出网名

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：公共卫生;统计;大数据
经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。

79 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2022-04-17 ms5000001799088561

现在期刊要求加载不进去了么？想投稿进不去要求

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2021-12-29 衣谷

文章题目有没有撰写模板？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2021-12-27 Mia

什么样的题目能让审稿人眼前一亮？

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2020-09-13 ms8381557919440379

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：过敏;COPD;ILD
经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。

176 0

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2020-07-28 ms1000000620964775

审稿速度:2.0
经验分享：一个多月直接被拒了，没有给任何理由

151 0

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2020-03-27 duyan1115

审稿速度:6.0 | 投稿命中率:50.0
经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。

165 0

[GetPortalCommentsPageByObjectIdResponse(id=2173286, encodeId=572a21e3286a8, content=11月6日投稿，一天后状态变成with editor，26日Decision in Process，相当于desk reject，但是12月6日才给发邮件，非要拖整整一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08558819328, createdName=ms9000001233094927, createdTime=Wed Dec 06 15:25:50 CST 2023, time=2023-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2167273, encodeId=60bf216e27338, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：未送审临床预测模型有外部验证，投稿7天后被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/14/adc0803ff06d9f6fc9d2bfc21391f246.jpg, createdBy=ac125183861, createdName=嘻嘻号, createdTime=Tue Nov 07 20:58:07 CST 2023, time=2023-11-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=959011, encodeId=8bba95901171, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：公共卫生;统计;大数据 经验分享：2020.6.30 with editor，2021.2.27收到审稿意见Major Revision。两位审稿人，一位提了两个小问题，另外一位问题十多条，认真修改后2021.3.6修回，2021.4.10收到二审意见Minor Revision，第一位审稿人表示没有进一步的评论，第二位审稿人两条小意见，第一建议稍微修改一下图，第二条意见编辑认为不重要，不强制要求改。2021.4.13二修修回，2021.4.16Accept。感觉该杂志倾向于接收COPD和哮喘的研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=338b5483706, createdName=想不出网名, createdTime=Wed Apr 21 10:49:44 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211992, encodeId=a620121199216, content=现在期刊要求加载不进去了么？想投稿进不去要求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38756406331, createdName=ms5000001799088561, createdTime=Sun Apr 17 20:48:56 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097785, encodeId=b1d3109e78505, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097786, encodeId=c07f109e78602, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884971, encodeId=b3f28849e11e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：过敏;COPD;ILD 经验分享：首选说这个杂志是英国的杂志，2020年3月27日投稿，40天一审完成让大修，问题大约有20个（3个reviewers），根据我的投稿经验，这就是editor-in-chief 感兴趣的文章才给机会大修，并不是3个reviewers友好，感觉就1个reviewer一般、一个友好、一个很不友好。咬着牙坚持了1个月修回了，然后半月后就让小修，小修4个问题，一个不友好，其他的都容易。1周后修回了，3天后最不友好的reviewer还是不肯善罢甘休，又小修1次。用了1天修回了，间隔2天告诉我接收了，下一步与出版商联系了。又用了1周就online了。后面我仔细想想，问的尖锐的问题的reviewer也是帮助我进一步完善数据和稿件。但是总体感觉，还是看这稿件主编到底感兴趣否？比如该杂志，三个版块，过敏、COPD、ILD，你只要在这里面就有机会吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7d91777881, createdName=ms8381557919440379, createdTime=Sun Sep 13 17:41:00 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804898, encodeId=a1b7804898dc, content=审稿速度:2.0 经验分享：一个多月直接被拒了，没有给任何理由, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6605340040, createdName=ms1000000620964775, createdTime=Tue Jul 28 15:54:09 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587510, encodeId=eac458e510f7, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：一审4个月，二审1.5月，总共半年时间接收，编辑比较nice。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4e31977927, createdName=duyan1115, createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584394, encodeId=fcff5843946f, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]

2020-02-08 爱爬树的松鼠

审稿速度:3.0 | 投稿命中率:50.0
经验分享：20190814with editor 20190819 under review 20190826 under review 20190920under review 20191005under review 20191013under review 20191028under review 20191117 minor revision 20191120 revision submit 20191121with editor 20191122under review 20200107 minor revision 20200112 revision submit 20200113 with editor 20200114under review 20200206 accept

177 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务